| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
CON
Concentra Group Holdings Parent, Inc.
|
Jul 14, 2026 | BUY |
Strong Buy
+5.8% avg upside
10 analysts
|
$37.00
20.19% Upside
|
· |
|
CNC
Centene
|
Jul 14, 2026 | BUY |
Buy
+0.2% avg upside
29 analysts
|
$78.00
13.89% Upside
|
-3.1% |
|
CYH
Community Health
|
Jul 14, 2026 | HOLD |
Sell
+34.9% avg upside
18 analysts
|
— | · |
|
CVS
CVS Health
|
Jul 14, 2026 | BUY |
Strong Buy
-2.3% avg upside
39 analysts
|
$118.00
11.54% Upside
|
+0.0% |
|
DVA
DaVita
|
Jul 14, 2026 | HOLD |
Hold
-27.7% avg upside
17 analysts
|
$250.00
7.47% Upside
|
· |
|
HCA
HCA Healthcare
|
Jul 14, 2026 | BUY |
Strong Buy
+14.1% avg upside
35 analysts
|
— | +2.5% |
|
HUM
Humana
|
Jul 14, 2026 | HOLD |
Buy
-13.4% avg upside
34 analysts
|
$415.00
2.16% Upside
|
· |
|
MD
Pediatrix Medical Group
|
Jul 14, 2026 | HOLD |
Buy
-12.8% avg upside
14 analysts
|
$28.00
13.99% Upside
|
· |
|
MOH
Molina Healthcare
|
Jul 14, 2026 | HOLD |
Buy
-1.8% avg upside
26 analysts
|
$250.00
4.17% Upside
|
+0.0% |
|
THC
Tenet Healthcare
|
Jul 14, 2026 | BUY |
Strong Buy
+15.0% avg upside
26 analysts
|
— | +0.0% |
|
ENSG
The Ensign Group
|
Jul 14, 2026 | HOLD |
Strong Buy
-3.8% avg upside
9 analysts
|
$202.00
21.20% Upside
|
+0.0% |
|
UNH
UnitedHealth
|
Jul 14, 2026 | BUY |
Strong Buy
-0.1% avg upside
36 analysts
|
$480.00
12.95% Upside
|
+0.0% |
|
ELV
Elevance Health
|
Jul 14, 2026 | BUY |
Strong Buy
+4.5% avg upside
32 analysts
|
$475.00
11.84% Upside
|
+0.0% |
|
PNTG
Pennant Group
|
Jul 14, 2026 | BUY |
Strong Buy
-7.5% avg upside
9 analysts
|
$48.00
21.49% Upside
|
· |
|
AVAH
Aveanna Healthcare Holdings
|
Jul 14, 2026 | HOLD |
Buy
-1.3% avg upside
17 analysts
|
$11.00
17.43% Upside
|
+0.0% |
|
ARDT
Ardent Health Partners, Inc.
|
Jul 14, 2026 | BUY |
Buy
+42.8% avg upside
16 analysts
|
$12.00
27.43% Upside
|
· |
|
PACS
PACS Group Inc
|
Jun 30, 2026 | BUY |
Strong Buy
+1.7% avg upside
9 analysts
|
— | +3.2% |
|
EHC
Encompass Health
|
Jun 26, 2026 | BUY |
Strong Buy
+2.8% avg upside
22 analysts
|
$140.00
30.03% Upside
|
+8.9% |
|
AHCO
AdaptHealth
|
Jun 24, 2026 | BUY |
Strong Buy
+37.8% avg upside
12 analysts
|
$14.00
38.03% Upside
|
+1.6% |
|
GRDN
Guardian Pharmacy Services, Inc. Class A
|
Jun 22, 2026 | BUY |
Strong Buy
+4.0% avg upside
7 analysts
|
$47.00
18.60% Upside
|
-2.9% |
|
FMS
Fresenius Medical Care
|
May 21, 2026 | HOLD |
Hold
+76.3% avg upside
14 analysts
|
$26.00
7.44% Upside
|
+11.6% |
|
RDNT
Radnet
|
May 19, 2026 | BUY |
Strong Buy
+27.2% avg upside
10 analysts
|
$90.00
43.33% Upside
|
+23.0% |
|
CI
Cigna
|
May 05, 2026 | BUY |
Strong Buy
+14.9% avg upside
29 analysts
|
$350.00
16.21% Upside
|
+7.1% |
|
LH
Labcorp Holdings
|
May 04, 2026 | BUY |
Strong Buy
-5.3% avg upside
36 analysts
|
$320.00
15.81% Upside
|
+10.5% |
|
OPCH
Option Care Health
|
May 01, 2026 | BUY |
Strong Buy
+38.3% avg upside
20 analysts
|
$30.00
40.56% Upside
|
+7.7% |
|
DGX
Quest Diagnostics
|
Apr 22, 2026 | HOLD |
Buy
-16.8% avg upside
33 analysts
|
— | +2.1% |
|
SAIC
Science Applications
|
Apr 03, 2023 | HOLD |
Buy
-9.6% avg upside
20 analysts
|
$120.00
5.06% Upside
|
+18.6% |
|
PRVA
Privia Health Group
|
Aug 12, 2022 | BUY |
Strong Buy
+13.3% avg upside
26 analysts
|
$48.00
70.78% Upside
|
-26.2% |
|
AGL
Agilon Health
|
Jul 14, 2022 | BUY |
Buy
-58.6% avg upside
26 analysts
|
$33.00
73.30% Downside
|
-35.7% |
|
HCSG
Healthcare Services
|
Oct 13, 2020 | HOLD |
Buy
+2.1% avg upside
12 analysts
|
— | +1.5% |
|
DE:FME
Fresenius Medical Care AG & Co. KGaA
|
May 02, 2019 | BUY |
Buy
+20.1% avg upside
22 analysts
|
$43.87
3.38% Upside
|
· |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.